Literature DB >> 16391129

Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes.

Karine Fiola1, Jean-Pierre Perreault, Benoit Cousineau.   

Abstract

The trans-acting antigenomic delta ribozyme, isolated from the human hepatitis delta virus, was shown to be highly stable and active in vitro, as well as in mammalian cell lines. However, the stability and gene-targeting competence of this small ribozyme have not been studied previously in bacterial cells. In this paper we describe the use of two variants of the trans-acting antigenomic delta ribozyme targeting the abundant EF-Tu mRNA in the industrially important gram-positive bacterium Lactococcus lactis. These two delta ribozyme variants were expressed at significant levels and were shown to be highly stable in vivo. The half-life of the EF-Tu mRNA was slightly but consistently reduced in the presence of the classical delta ribozymes (7 to 13%). In contrast, delta ribozymes harboring a specific on/off riboswitch (SOFA-delta ribozymes) targeting the same sites on the EF-Tu mRNA considerably reduced the half-life of this mRNA (22 to 47%). The rates of catalysis of the SOFA-delta ribozymes in L. lactis were similar to the rates determined in vitro, showing that this new generation of delta ribozymes was highly efficient in these bacterial cells. Clearly, SOFA-delta ribozymes appear to be an ideal means for development of gene inactivation systems in bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391129      PMCID: PMC1352214          DOI: 10.1128/AEM.72.1.869-879.2006

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  48 in total

1.  Predicting oligonucleotide affinity to nucleic acid targets.

Authors:  D H Mathews; M E Burkard; S M Freier; J R Wyatt; D H Turner
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

2.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

Review 3.  Ribozymes in the age of molecular therapeutics.

Authors:  Sepideh Bagheri; Mohammed Kashani-Sabet
Journal:  Curr Mol Med       Date:  2004-08       Impact factor: 2.222

4.  Functional characterization of the SOFA delta ribozyme.

Authors:  Lucien Junior Bergeron; Cédric Reymond; Jean-Pierre Perreault
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

5.  Delta ribozyme has the ability to cleave in transan mRNA.

Authors:  G Roy; S Ananvoranich; J P Perreault
Journal:  Nucleic Acids Res       Date:  1999-02-15       Impact factor: 16.971

6.  Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme.

Authors:  Patrick Deschênes; Jonathan Ouellet; Jonathan Perreault; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

Review 7.  Catalytic strategies of the hepatitis delta virus ribozymes.

Authors:  I-hung Shih; Michael D Been
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

8.  Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity.

Authors:  O P Kuipers; M M Beerthuyzen; R J Siezen; W M De Vos
Journal:  Eur J Biochem       Date:  1993-08-15

9.  Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction.

Authors:  O P Kuipers; M M Beerthuyzen; P G de Ruyter; E J Luesink; W M de Vos
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

10.  Improved cloning vectors and transformation procedure for Lactococcus lactis.

Authors:  J M Wells; P W Wilson; R W Le Page
Journal:  J Appl Bacteriol       Date:  1993-06
View more
  7 in total

1.  RiboSubstrates: a web application addressing the cleavage specificities of ribozymes in designated genomes.

Authors:  Jean-François Lucier; Lucien Junior Bergeron; Francis P Brière; Rodney Ouellette; Sherif Abou Elela; Jean-Pierre Perreault
Journal:  BMC Bioinformatics       Date:  2006-10-31       Impact factor: 3.169

2.  Investigating a new generation of ribozymes in order to target HCV.

Authors:  Michel V Lévesque; Dominique Lévesque; Francis P Brière; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

3.  Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting.

Authors:  Michel V Lévesque; Samuel G Rouleau; Jean-Pierre Perreault
Journal:  Nucleic Acid Ther       Date:  2011-07-08       Impact factor: 5.486

4.  Silencing of amyloid precursor protein expression using a new engineered delta ribozyme.

Authors:  Manel Ben Aissa; Marie-Claude April; Lucien-Junior Bergeron; Jean-Pierre Perreault; Georges Levesque
Journal:  Int J Alzheimers Dis       Date:  2012-02-12

5.  A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.

Authors:  Julie Motard; Ronan Rouxel; Alexandra Paun; Veronika von Messling; Martin Bisaillon; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

Review 6.  Modulating RNA structure and catalysis: lessons from small cleaving ribozymes.

Authors:  Cedric Reymond; Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  Cell Mol Life Sci       Date:  2009-08-30       Impact factor: 9.261

7.  A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.

Authors:  Robert J Scarborough; Michel V Lévesque; Etienne Boudrias-Dalle; Ian C Chute; Sylvanne M Daniels; Rodney J Ouellette; Jean-Pierre Perreault; Anne Gatignol
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-29       Impact factor: 10.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.